$31.37
-0.28-0.88%
At close: -
$31.37
0.000.00%
After Hours: 4:00 PM EDT
Royalty Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Royalty Pharma using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RPRX | Royalty Pharma | $0.98 | $1.10 | — | — | $568.00M | — | — | — | 05/08/2025 | Get Alert |
RPRX | Royalty Pharma | $1.15 | $1.05 | $1.16 | 10.48% | $596.00M | $743.60M | $594.00M | -20.12% | 02/11/2025 | Get Alert |
RPRX | Royalty Pharma | $0.79 | $0.93 | $1.04 | 11.83% | $536.00M | $696.10M | $565.00M | -18.83% | 11/06/2024 | Get Alert |
RPRX | Royalty Pharma | $0.84 | $0.99 | $0.96 | -3.03% | $538.00M | $628.26M | $537.00M | -14.53% | 08/08/2024 | Get Alert |
RPRX | Royalty Pharma | $1.60 | $0.99 | $0.98 | -1.01% | $684.00M | $663.22M | $568.00M | -14.36% | 05/09/2024 | Get Alert |
RPRX | Royalty Pharma | $1.56 | $0.99 | $1.15 | 16.16% | $566.00M | $673.65M | $596.00M | -11.53% | 02/15/2024 | Get Alert |
RPRX | Royalty Pharma | $0.32 | $0.77 | $0.79 | 2.60% | $573.46M | $614.36M | $536.00M | -12.75% | 11/08/2023 | Get Alert |
RPRX | Royalty Pharma | $0.70 | $0.83 | $0.84 | 1.20% | $535.96M | $538.52M | $538.00M | -0.10% | 08/08/2023 | Get Alert |
RPRX | Royalty Pharma | $0.60 | $1.27 | $1.60 | 25.98% | $562.00M | $852.90M | $684.00M | -19.80% | 05/09/2023 | Get Alert |
RPRX | Royalty Pharma | $0.80 | $1.52 | $1.56 | 2.63% | $576.00M | $937.93M | $566.00M | -39.65% | 02/15/2023 | Get Alert |
RPRX | Royalty Pharma | $0.24 | $0.71 | $0.32 | -54.93% | $585.77M | $585.37M | $573.46M | -2.03% | 11/08/2022 | Get Alert |
RPRX | Royalty Pharma | $0.73 | $0.78 | $0.70 | -10.26% | $555.00M | $542.18M | $535.96M | -1.15% | 08/04/2022 | Get Alert |
RPRX | Royalty Pharma | $0.67 | $0.73 | $0.60 | -17.81% | $573.03M | $599.76M | $562.00M | -6.30% | 05/05/2022 | Get Alert |
RPRX | Royalty Pharma | $0.27 | $0.77 | $0.80 | 3.90% | $572.00M | $556.79M | $576.00M | 3.45% | 02/15/2022 | Get Alert |
RPRX | Royalty Pharma | $0.48 | — | $0.24 | — | $538.00M | $578.20M | $585.77M | 1.31% | 11/10/2021 | Get Alert |
RPRX | Royalty Pharma | $0.99 | $0.69 | $0.73 | 5.80% | $511.00M | $483.42M | $555.00M | 14.81% | 08/11/2021 | Get Alert |
RPRX | Royalty Pharma | — | $0.65 | $0.18 | -72.31% | — | $509.70M | $573.03M | 12.42% | 05/11/2021 | Get Alert |
RPRX | Royalty Pharma | — | $0.69 | $0.27 | -60.87% | — | $480.71M | $572.00M | 18.99% | 02/17/2021 | Get Alert |
RPRX | Royalty Pharma | — | $0.64 | $0.48 | -25.00% | — | $462.45M | $538.00M | 16.34% | 11/10/2020 | Get Alert |
RPRX | Royalty Pharma | — | $0.61 | $0.99 | 62.30% | — | $468.96M | $511.00M | 8.96% | 08/12/2020 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-11 | $1.16 | $1.05 | 10.5 % |
Q3 | 2024-11-06 | $1.04 | $0.93 | 11.8 % |
Q2 | 2024-08-08 | $0.96 | $0.99 | -3.03 % |
Q1 | 2024-05-09 | $0.98 | $0.99 | -1.01 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-11 | $594.00M | $743.60M | -20.1 % |
Q3 | 2024-11-06 | $565.00M | $696.10M | -18.8 % |
Q2 | 2024-08-08 | $537.00M | $628.26M | -14.5 % |
Q1 | 2024-05-09 | $568.00M | $663.22M | -14.4 % |
Royalty Pharma (RPRX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 11, 2025 for Q4.
The Actual EPS was $1.16, which beat the estimate of $1.05.
The Actual Revenue was $594M, which missed the estimate of $743.6M.
Browse earnings estimates, EPS, and revenue on all stocks.